chartexchange

Nektar Therapeutics Announces Third Quarter 2026 Financial Results

PR Newswire | Nov 12, 2026 4:15 PM EST

SAN FRANCISCO, Nov. 12, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced its financial results for the third quarter ended September 30, 2026, and provided a business update. Cash and investments in marketable securities on September 30, 2026, were $952.9 million as...

Read original article